Similarly, MFN1/2 upregulated in L1210 cells was responsible for the resistance to cisplatin treatment, whereas the inhibition of mitochondrial fusion by silencing of MFNs sensitized neuroblastoma cells to cisplatin (24, 96). The gene discussed is MFN1; the disease is neuroblastoma.